|
|
|
|
 |
Serial Alzheimer's Disease and MCI Prospective Longitudinal Evaluation
The SAMPLE Registry
The SAMPLE Registry is a collection of correlated data and biological samples for the investigation of markers of cognitive decline.
The SAMPLE Registry will enroll at least 200 subjects, with either MCI or AD, aged 50 years and above. All subjects will be recruited, evaluated, cognitively studied, and sampled from 12-15 US based, experienced investigative sites. Enrollment is expected to take about 2 years to complete.
Key aspects of subjects' cognition including memory and attention will be evaluated every six months with simultaneous biological sample banking for a period of 5 or more years.
Samples and data will be made available to clients on a monthly basis. Special attention will be paid to maintaining patients in the study by providing incentives for continued participation to patients and/or care givers.Six monthly samples with matched clinical data will be available on a longitudinal basis to our clients. Custom requests for additional sample types, as well as more complex clinical, laboratory and/or radiographic evaluations within selected subpopulations will be entertained as the registry matures.
SAMPLE Registry Press Release
SAMPLE Registry
Number of Subjects --
March 21 2008
|
|
SAMPLE Type
|
Visit 1
|
|
DNA,Serum,Plasma, PAXGene, CSF
|
8 AD
5 MCI
|
|
|
|
|
|
|
DNA Samples PrecisionMed - Human Genetic Material Biobank
DNA Samples, RNA Samples, Plasma Samples, Serum Samples, Urine Samples, CSF Samples, PBMCs
Alzheimer's Disease, Alzheimer's DNA, Alzheimer's CSF, Alzheimer's plasma, Alzheimer's PBMC, Alzheimer's serum
|
